substitute for tirzepatide Compounded Alternatives: What's Next Patients After FDA Decision? Zepbound Alternatives For Weight Loss

With over 25 years of clinical experience, Einav has seen countless fad diets come and godiets that many people try without considering the risks they could pose

Kailera IPO'd in 2025 with HRS9531 (dual GLP-1/GIP, Phase 3 China readout ~17.7% weight loss February 2026) as its lead asset and HRS-4729 (the triple agonist) as an earlier-stage follow-on

Time and further research will tell, but there are genuine safety concerns associated with the widespread use of these medications

Expect prior authorization requests

There is no FDA-approved peptide for raising testosterone, and any honest answer to what is the best peptide to increase testosterone has to start there